Management of Study Medications

Bohaychuk, Wendy; Ball, Graham
September 2000
Applied Clinical Trials;Sep2000, Vol. 9 Issue 9, p38
Academic Journal
Focuses on the management of study medications in clinical trials. Existence of a written policy for medication management; Documentation of the requirements for study medication management; Routes for the medication shipment to study sites; Safety and security of medication storage.


Related Articles

  • Measurement Methods of Drug Consumption as a Secondary Judgment Criterion for Clinical Trials in Chronic Rheumatic Diseases. Constant, Florence; Guillemin, Francis; Herbeth, Bernard; Collin, Jean François; Boulangé, Michel // American Journal of Epidemiology;1997, Vol. 145 Issue 9, p826 

    Drug consumption is sometimes used as a secondary judgment criterion for clinical trials. Many measurement methods are available to quantify drug consumption. Several methods were applied in a rheumatic disease trial involving 121 patients with chronic low back pain who lived around...

  • Headaches over painkillers. Sweet, Melissa // Bulletin with Newsweek;04/11/2000, Vol. 118 Issue 6219, p52 

    Highlights the importance of developing better post-marketing surveillance of drugs in Australia. Adverse reactions of drugs; Major problem with clinical trials; International concern about the use on children of drugs that have been tested only on adults.

  • Effects of methylphenidate on saccadic responses in patients with ADHD. Klein, C.; Fischer, B.; Hartnegg, K. // Experimental Brain Research;Jul2002, Vol. 145 Issue 1, p121 

    This study examined the effects of methylphenidate on different measures of saccade control, using a repeated measurement design, and the experimental and statistical control of practice effects. Twenty-seven boys with ADHD (mean age 12.6 years, range 10–15 years) were randomly assigned...

  • Step monitoring to improve ARTERial health (SMARTER) through step count prescription in type 2 diabetes and hypertension: trial design and methods. Dasgupta, Kaberi; Rosenberg, Ellen; Daskalopoulou, Stella S. // Cardiovascular Diabetology;2014, Vol. 13 Issue 1, p1 

    Background With increasing numbers of type 2 diabetes (DM2) and hypertension patients, there is a pressing need for effective, time-efficient and sustainable strategies to help physicians support their patients to achieve higher physical activity levels. SMARTER will determine whether...

  • Labopharm Phase III Trial with Trazodone Hits Mark. Morrison, Trista // BioWorld Today;2/11/2008, Vol. 19 Issue 28, p1 

    The article reports the results of the phase three clinical trial for antidepressant drug trazodone from Labopharm Inc. The company claimed a drop out rate of 25.5 percent, which was on par with other depression studies. Drop out rate was 21 percent in the placebo group and 30.2 percent in the...

  • THE Adherence Survival Kit. Lusk, Christine M.; Bettencourt, Judy; Carroll, Lillian; Egan, Debra; Ford, Charles E.; Kingry, Connie; Johnson, Janice; Sullivan, Sheila; Nwachuku, Chuke; Probstfield, Jeffrey l. // Applied Clinical Trials;Oct2004, Vol. 13 Issue 10, p40 

    Focuses on the Adherence Survival Kit (ASK), an organized approach to the management of retention and adherence issues in a large and long-term clinical trial received by the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial medical clinics in the U.S. Effectiveness of...

  • A Trial of Automated Safety Alerts for Inpatient Digoxin Use with Computerized Physician Order Entry. Galanter, William L.; Polikaitis, Audrius; Didomenico, Robert J. // Journal of the American Medical Informatics Association;Jul/Aug2004, Vol. 11 Issue 4, p270 

    Objective: Automated clinical decision support (CDS) has shown promise in improving safe medication use. The authors performed a trial of CDS, given both during computerized physician order entry (CPOE) and in response to new laboratory results, comparing the time courses of clinician behaviors...

  • Call for a new approach to the process of clinical trials and drug registration. Jones, Thomas C. // BMJ: British Medical Journal (International Edition);04/14/2001, Vol. 322 Issue 7291, p920 

    Addresses the need for a new approach to the process of clinical trials and drug registration. Thoughts on the cost of clinical trials for drug registration; Need for a fresh approach to drug registration; Suggestions.

  • Pharmacotherapy of Chronic Heart Failure in the Elderly: A Review of the Evidence. Ripley, Toni L.; Hennebry, Thomas A. // Clinical Medicine Insights: Therapeutics;2010, Issue 2, p353 

    Heart failure (HF) is a very prevalent disease in the United States and in Europe, with the highest prevalence among older patients. Population estimates suggest substantial growth among the elderly over the next four decades. However, older patients are underrepresented in clinical trials...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics